Stock Market News
Latest financial news · Updated May 23, 2026
The Campbell’s Company (CPB) Names Joshua Levine Chief Investor Relations Officer
The panelists generally agree that Joshua Levine's appointment as CPB's Chief Investor Relations Officer is unlikely to significantly impact the …
Sony Group (SONY) Margins at Risk Amid Rising Memory Prices, Bernstein Warns
The panel is divided on Sony's ability to navigate potential memory price spikes, with some arguing that Sony can pass …
Oppenheimer Reiterates Perform Rating on Meta Platforms (META) Stock
The panelists debated Meta's cost-cutting measures and AI investments, with Claude and Gemini expressing concerns about potential value traps, execution …
SoFi Technologies Inc. (SOFI) Refutes $312M Debt Misstatement Claims Considers Legal Action
The panel is largely bearish on SoFi following Muddy Waters' report, with concerns around unrecorded debt, EBITDA inflation, and potential …
Sinking Crude Oil Prices Undercut Sugar Prices
The panel's net takeaway is that the 9% drop in crude oil prices is bearish for sugar futures due to …
ADMA Biologics (ADMA) Announces $200M Capital Return Program Including $125M ASR Agreement
ADMA's $200M capital return in 2026, including a $125M ASR, signals confidence in cash generation and is seen as a …
Caris Life Sciences (CAI) Expands AI Insights Portfolio With Signature to Predict Ovarian Cancer Platinum Resistance
Caris Life Sciences' (CAI) new AI signature predicting platinum resistance in high-grade serous ovarian cancer (HGSOC) is an incremental feature …
The Boeing Company (BA) Secures 777 FAA Node Amid Soaring Demand
The panelists agree that the 777-9's move to Phase 4 testing is a significant milestone, but they remain cautious due …
Ondas (ONDS) Acquires INDO Earth Moving Following $140M Military Heavy Engineering Tender
The panel expresses concerns about Ondas' acquisition of INDO, with a distant revenue cliff, potential cash burn, and dilution risks. …
Freddie Mac Stock Just Hit a New 52-Week Low. Should You Buy the Dip or Stay Far, Far Away?
The panel consensus is that FMCC's 51% YTD collapse reflects political uncertainty and lack of privatization progress, with no clear …
UBS Wary of Nike Inc. (NKE)’s Weak Global Sales but Barclays Confident of Bounce Back
The panel consensus is bearish, with concerns about Nike's near-term demand issues, potential margin compression, and the impact of a …
ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include ANKTIVA for Papillary-Only NMIBC
The panelists agree that ImmunityBio's (IBRX) ANKTIVA getting NCCN Category 2A inclusion for papillary-only, BCG-unresponsive NMIBC is commercially meaningful, but …